Pharmacokinetics of ceftriaxone administered by the intravenous, intramuscular or subcutaneous routes to dogs

Journal of Veterinary Pharmacology and Therapeutics

Volumn 25, Issue 1, 2002, Pages 73-76

  Rebuelto, M ^a   Albarellos, G ^a   Ambros, L ^a   Kreil, V ^a   Montoya, L ^a   Bonafine, R ^a   Otero, P ^a   Hallu, R ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHEX; CEFTRIAXONE;

AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TOLERANCE; FEMALE; MALE; MEAN RESIDENCE TIME; NONHUMAN; PRIORITY JOURNAL; STEADY STATE;

ANIMALS; AREA UNDER CURVE; CEFTRIAXONE; CEPHALOSPORINS; CROSS-OVER STUDIES; DOGS; FEMALE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE;

CANIS FAMILIARIS;

EID: 0036268062     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2002.00389.x     Document Type: Article

References (19)

1. Simplified, accurate method of antibiotic assay of clinical specimens
2. Pharmacokinetics and protein binding of ceftriaxone during pregnancy
3. Pharmacokinetics of ceftriaxone in mares
4. Investigation of bioequivalence and tolerability of intramuscular ceftriaxone injections by using 1% lidocaine, buffered lidocaine, and sterile water diluents
5. Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pnemococci with various susceptibilities to penicillin
6. Influence of assay methodology on the measurement of free serum ceftriaxone concentrations
7. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis
8. Comparative pharmacokinetics of YM-13115, ceftriaxone, and ceftazidime in rats, dogs, and rhesus monkeys
9. Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers
10. Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin
11. Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents
12. Pharmacokinetics of ceftriaxone in neonatal foals
13. Pharmacokinetics of ceftriaxone in healthy horses
14. Pharmacokinetics and bioavailability of ceftriaxone administered intravenously and intramuscularly to calves
15. Correlation of pharmacodynamic parameters of five beta-lactam antibiotics with therapeutic efficacies in an animal model
16. Kinetic disposition of intravenous ceftriaxone in normal subjects and patients with renal failure on hemodialysis or peritoneal dialysis
17. Effect of protein binding on penetration of beta-lactams into rabbit peripheral lymph
18. Single-dose pharmacokinetics of ceftriaxone in healthy Chinese adults